Uveitis Market Insight, Epidemiology and Market Forecast to 2034: Assessment of Competitors, Market, Current Trends and Upcoming Treatments
April 23, 2024 03:21 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Uveitis Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.The latest report on the...
Autoimmune Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034
March 25, 2024 19:44 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Autoimmune Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ResearchAndMarkets.com's offering. ...
Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution Channel - Forecast 2024-2030
March 19, 2024 17:49 ET
|
Research and Markets
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution...
Unlocking Opportunities: Uveitis Market Forecast and Treatment Trends for the Next Decade
July 31, 2023 06:53 ET
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Uveitis - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive...
Clearside Biomedical Asia-Pacific Partner Arctic Vision Announces the Acceptance in Australia of its New Drug Application for Suprachoroidal Use of Arcatus® for the Treatment of Uveitic Macular Edema
July 10, 2023 07:05 ET
|
Clearside Biomedical, Inc.
- XIPERE® is referred to as Arcatus (ARVN001) by Arctic Vision – ALPHARETTA, Ga., July 10, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company...
Anterior Uveitis Treatment Market (2021 - 2026): Key Global Players Include Abbvie, Novartis and Regeneron
March 10, 2022 04:08 ET
|
Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Anterior Uveitis Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
Europe Uveitis Markets and Competitive Landscape Report 2021-2026
September 10, 2021 03:28 ET
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Europe Uveitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Europe Uveitis Market and...
Global Uveitis Markets and Competitive Landscape Report 2021-2026
September 10, 2021 03:13 ET
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Uveitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Global Uveitis Market and...
Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE™ for Treatment of Macular Edema Associated with Uveitis
May 03, 2021 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Global Anterior Uveitis Treatment Market (2020 to 2026) - Featuring Mylan, Allergan & Cadila Pharmaceuticals Among Others
February 22, 2021 05:48 ET
|
Research and Markets
Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Anterior uveitis treatment Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global anterior uveitis treatment...